ArticleCancer research and treatment2022

Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.

Hyojin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.